LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
LY487379 is a selective human mGluR2 positive allosteric modulator (PAM). LY487379 potentiates glutamate-stimulated [ 35 S]GTPγS binding with EC 50 values of 1.7 μM and >:10 μM for mGlu2 and mGlu3 receptors respectively. LY487379 promotes
BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency
BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency
BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency
BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency